Castle Biosciences (CSTL) P/E (2019 - 2026)
Castle Biosciences (CSTL) P/E from Sep 30, 2019 to Jul 21, 2026. The TTM Castle Biosciences (CSTL) P/E is -58.50. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Castle Biosciences (CSTL)
| Year | P/E | Change |
|---|---|---|
| 2026 | -58.50 | +25.71% |
| 2025 | -46.54 | -213.16% |
| 2024 | 41.13 | -639.04% |
| 2023 | -7.63 | -33.54% |
| 2022 | -11.48 | -66.80% |
| 2021 | -34.58 | -78.47% |
| 2020 | -160.62 | -277.22% |
| 2019 | 90.63 | N/A |
Comparison Castle Biosciences (CSTL) P/E with competitors
Castle Biosciences (CSTL) P/E is -58.50.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -101.79% |
| MBAI | CheckCap Ltd | 1.71 | -102.93% |
| FONR | Fonar Corp | 15.48 | -126.46% |
| QGEN | Qiagen NV | 20.03 | -134.24% |
| DGX | Quest Diagnostics Inc | 22.47 | -138.41% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -140.80% |
| IQV | IQVIA Holdings Inc | 25.28 | -143.21% |
| A | Agilent Technologies Inc | 26.96 | -146.08% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -153.89% |
| MTD | Mettler-Toledo International Inc | 32.45 | -155.47% |
| MEDP | Medpace Holdings Inc | 32.55 | -155.64% |
| DHR | Danaher Corp | 38.55 | -165.90% |
| IDXX | Idexx Laboratories Inc | 40.58 | -169.35% |
| ILMN | Illumina Inc | 44.12 | -175.41% |
| RVTY | Revvity Inc | 52.68 | -190.05% |
| VCYT | Veracyte Inc | 53.71 | -191.81% |
| ICLR | Icon Plc | 57.45 | -198.20% |
| SHC | Sotera Health Company | 74.08 | -226.63% |
| WAT | Waters Corp | 102.79 | -275.69% |